000 02783cam a2200337 a 4500
003 EG-GiCUC
005 20250223032540.0
008 200811s2020 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.12.02.Ph.D.2020.Di.B
100 0 _aDina Mostafa Mohammed Mohammed
245 1 0 _aBiochemical studies on the relation between tamoxifen, nano-nutrients and some bioactive components and gene expression in experimental breast cancer /
_cDina Mostafa Mohammed Mohammed ; Supervised Abdou Osman Abdelhamid , Afaf Ezzat Abbas
246 1 5 _aدراسات بيوكيميائية عن العلاقة بين التاموكسفين: المغذيات النانو وبعض المركبات النشطة حيويا والتعبير الجينى فى سرطان الثدى التجريبي
260 _aCairo :
_bDina Mostafa Mohammed Mohammed ,
_c2020
300 _a289 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry
520 _aThis work had been carried out to study converting drug (Tamoxifen), some nutrients (yeast) and bioactive compounds (Silymarin and Isoflavone) to nanoparticles and study their different effects in nano and normal scale on gene expression. Encourage the use of nanotechnology to limit the development and spread of breast cancer and the inhibitory effect of them on development of toxic material of mammary tumor for 180 days against with a single oral dose of (25 mg/kg) 7,12-dimethylbenz[a]anthracene (DMBA) in female rats. The body weight and food consumption will be examined. Upon the completion of the study, the histopathological studies on the breast tissues will be performed. The therapeutic and protective effects of these compounds in nano and normal scale will be evaluated using the appropriate parameters to determine the level of several chemicals related to oxidative damage (8-OHdG, Lipid Peroxide, TAC), Apoptosis, Plasma Estrogen and ErbB-2 in the blood samples. Also, the gene expression of ErbB-2 will be investigated in the blood samples. Finally, all the experimental results evaluated, tabulated and statistically analyzed. In conclusion, Breast cancer is highly curable if diagnosed with nutrients or medications whether in their normal or nano particles form at an early stage
530 _aIssued also as CD
653 4 _aBioactive Components
653 4 _aBreast Cancer
653 4 _aExperimental Rats
700 0 _aAbdou Osman Abdelhamid ,
_eSupervisor
700 0 _aAfaf Ezzat Abbas ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c77182
_d77182